Investigation to Understand and Optimize Psilocybin
NCT: NCT06512194 · RECRUITING
Brief Summary
This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. It will also assess whether different post-dosing interventions, including a non-invasive technique called transcutaneous auricular Vagus Nerve Stimulation (taVNS), influence various psychological and behavioral outcomes. In addition, the study will explore objective measures of real-world social behavior and identify early behavioral responses that may be associated with long-term treatment outcomes.
Frequently Asked Questions
What is Investigation to Understand and Optimize Psilocybin?
Investigation to Understand and Optimize Psilocybin is a clinical trial registered under NCT06512194. Current status: RECRUITING.
What is the status of NCT06512194?
The current status of NCT06512194 (Investigation to Understand and Optimize Psilocybin) is: RECRUITING.
When did Investigation to Understand and Optimize Psilocybin start?
Investigation to Understand and Optimize Psilocybin started on 2025-05-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.